Hormone therapy and breast cancer risk: new screening study launches

NCT ID NCT06383026

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is for people aged 40-75 who are on hormone therapy (estrogen, progesterone, or testosterone). It aims to understand their breast cancer risk and improve screening by using mammograms and breast ultrasounds. Researchers will also interview participants to learn about their experiences and any barriers to getting screened.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help design better breast cancer screening programs tailored for people on hormone therapy.

What could go wrong

This is a small pilot study (130 participants) focused on gathering data, not testing a treatment. Results may not apply to everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Email: •••••@•••••